Synergistic Effect of Muramyldipeptide with Lipopolysaccharide or Lipoteichoic Acid To Induce Inflammatory Cytokines in Human Monocytic Cells in Culture
- 1 April 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (4) , 2045-53
- https://doi.org/10.1128/iai.69.4.2045-2053.2001
Abstract
An analog of 1α,25-dihydroxyvitamin D3, 22-oxyacalcitriol (OCT), differentiated human monocytic THP-1 and U937 cells to express membrane CD14 and rendered the cells responsive to bacterial cell surface components. Both THP-1 and U937 cells expressed Toll-like receptor 4 (TLR4) on the cell surface and TLR4 mRNA in the cells, irrespective of OCT treatment. In contrast, OCT-treated U937 cells scarcely expressed TLR2 mRNA, while OCT-treated THP-1 cells expressed this transcript. Muramyldipeptide (MDP) by itself exhibited only a weak ability to induce secretion of inflammatory cytokines such as interleukin-8 (IL-8) in the OCT-differentiated THP-1 cells but showed marked synergistic effects withSalmonellalipopolysaccharide (LPS) or lipoteichoic acid (LTA) fromStaphylococcus aureus, both of which exhibited strong activities. Combinatory stimulation with LPS plus LTA did not show a synergistic effect on OCT-differentiated THP-1 cells. Similar results were observed in OCT-differentiated U937 cells, although combination experiments were carried out only with MDP plus LPS. Anti-CD14 monoclonal antibody (MAb) MY4, anti-TLR4 MAb HTA125, and the synthetic lipid A precursor LA-14-PP almost completely inhibited the IL-8-inducing activities of LTA as well as LPS on OCT-treated THP-1 cells, but these treatments increased MDP activity. OCT-treated THP-1 cells primed with MDP exhibited enhanced production of IL-8 upon stimulation with LPS, while the cells primed with LPS showed no change in production upon stimulation with MDP. MDP up-regulated mRNA expression of an adapter molecule to TLRs, MyD88, to an extent similar to that for LPS in OCT-treated THP-1 cells. These findings suggested that LTA as well as LPS activated human monocytic cells in a CD14- and TLR4-dependent manner, whereas MDP exhibited activity in a CD14-, TLR4-, and probably TLR2-independent manner and exhibited synergistic and priming effects on the cells for cytokine production in response to various bacterial components.Keywords
This publication has 46 references indexed in Scilit:
- Synergistic Epithelial Responses to Endotoxin and a Naturally Occurring Muramyl PeptideInfection and Immunity, 2000
- Brief Communication The interaction of immunomodulator muramyl dipeptide with peripheral 5-HT receptors: overview of the current stateInternational Journal of Immunopharmacology, 1999
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- Micrococcus luteuscells and cell walls induce anaphylactoid reactions accompanied by early death and serum cytokines in mice primed with muramyl dipeptideFEMS Immunology & Medical Microbiology, 1997
- Enzymatically Deacylated Lipopolysaccharide (LPS) Can Antagonize LPS at Multiple Sites in the LPS Recognition PathwayJournal of Biological Chemistry, 1995
- Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial EndotoxinAnnual Review of Immunology, 1995
- Bacterial EndotoxinsScientific American, 1992
- Lipopolysaccharide antagonistsImmunology Today, 1992
- Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide releaseBiochemical and Biophysical Research Communications, 1985
- Endotoxin-induced antitumor activity in the mouse is highly potentiated by muramyl dipeptideCancer Letters, 1984